Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-2876PMID 17178880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

  2015cited by this paper
• Treatment for Advanced Tumors: Src Reclaims Center Stage

  2006cited by this paper
• Radiation combined with EGFR signal inhibitors: head and neck cancer focus.

  2006cited by this paper
• Coxibs and cardiovascular side-effects: from light to shadow.

  2006cited by this paper
• Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.

  2006cited by this paper
• Advances in molecular diagnostics and therapeutics in head and neck cancer

  2006cited by this paper
• Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

  2006cited by this paper
• Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.

  2005cited by this paper
• Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft Model

  2005cited by this paper
• Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture.

  2005cited by this paper
• Treatment of Lung Cancer Using Clinically Relevant Oral Doses of the Cyclooxygenase-2 Inhibitor Rofecoxib: Potential Value as Adjuvant Therapy After Surgery

  2005cited by this paper
• Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis

  2005influential reference
• Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.

  2005cited by this paper
• The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.

  2005cited by this paper
• Distinct ADAM Metalloproteinases Regulate G Protein-coupled Receptor-induced Cell Proliferation and Survival*

  2004cited by this paper
• Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion

  2004cited by this paper
• Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells

  2004cited by this paper
• Simultaneously Targeting Epidermal Growth Factor Receptor Tyrosine Kinase and Cyclooxygenase-2, an Efficient Approach to Inhibition of Squamous Cell Carcinoma of the Head and Neck

  2004cited by this paper
• Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.

  2004cited by this paper
• Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells

  2004influential reference
• Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor Receptor*

  2003cited by this paper
• Epidermal Growth Factor Receptor-stimulated Activation of Phospholipase Cγ-1 Promotes Invasion of Head and Neck Squamous Cell Carcinoma

  2003cited by this paper
• Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor

  2003cited by this paper
• Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

  2003cited by this paper
• TACE cleavage of proamphiregulin regulates GPCR‐induced proliferation and motility of cancer cells

  2003influential reference
• Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a “biased agonist” mechanism

  2002cited by this paper
• Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.

  2002cited by this paper
• Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.

  2002cited by this paper
• Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

  2002cited by this paper
• Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

  2001cited by this paper
• EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin.

  2001cited by this paper
• Effects of bradykinin on cytoplasmic calcium and motility in murine bladder tumor cells.

  2001cited by this paper
• Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.

  2000cited by this paper
• Expression and regulation of c‐erbB ligands in human head and neck squamous carcinoma cells

  2000influential reference
• The m3 muscarinic acetylcholine receptor is coupled to mitogen-activated protein kinase via protein kinase C and epidermal growth factor receptor kinase.

  2000cited by this paper
• Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.

  2000cited by this paper
• EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

  1999cited by this paper
• Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.

  1998cited by this paper
• Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

  1998cited by this paper
• Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival

  1998cited by this paper
• Downmodulation of TGF‐α protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells

  1998cited by this paper
• Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation.

  1997cited by this paper
• Critical Role of Calcium- dependent Epidermal Growth Factor Receptor Transactivation in PC12 Cell Membrane Depolarization and Bradykinin Signaling*

  1997cited by this paper
• Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

  1996cited by this paper
• Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.

  1989cited by this paper
• Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck.

  1988cited by this paper

• Let-7b miRNA-loaded nanostructures inhibited human tongue squamous cell carcinoma metastasis by the MOR-SRC-EGFR axis

  2024cites this paper
• CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis

  2024cites this paper
• ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component

  2023cites this paper
• Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma

  2023cites this paper
• Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling.

  2023cites this paper
• New insights into RAS in head and neck cancer.

  2023cites this paper
• Alcohol and Head and Neck Cancer: Updates on the Role of Oxidative Stress, Genetic, Epigenetics, Oral Microbiota, Antioxidants, and Alkylating Agents

  2022cites this paper
• An overview of kinin mediated events in cancer progression and therapeutic applications.

  2022cites this paper
• NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models

  2022cites this paper
• A novel methodology for head and neck carcinoma treatment stage detection by means of model checking

  2022cites this paper
• Lipid Raft Facilitated Receptor Organization and Signaling: A Functional Rheostat in Embryonic Development, Stem Cell Biology and Cancer

  2022cites this paper
• Monoclonal Antibodies for Cancer Immunotherapy

  2020cites this paper
• FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT/mTOR signaling

  2020cites this paper
• P2Y2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines.

  2020cites this paper
• Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease

  2020cites this paper
• The landscape of GPCR signaling in the regulation of epidermal stem cell fate and skin homeostasis

  2020cites this paper
• GPCRs in head and neck squamous cell carcinoma

  2020cites this paper
• GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17

  2020cites this paper
• A Brief History of Single-Particle Tracking of the Epidermal Growth Factor Receptor

  2019cites this paper
• Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism.

  2019cites this paper
• Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles

  2019cites this paper
• ALDH1 as a prognostic marker for lymph node metastasis in OSCC

  2018cites this paper
• Bifunctional ligands of the bradykinin B2 and B1 receptors: An exercise in peptide hormone plasticity.

  2018cites this paper
• Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.

  2017cites this paper
• GPCRs and EGFR - Cross-talk of membrane receptors in cancer.

  2017cites this paper
• PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells

  2017cites this paper
• Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells.

  2017cites this paper
• Therapeutic implication of mTORC2 in oral squamous cell carcinoma.

  2017cites this paper
• Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway

  2017cites this paper
• Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells

  2016cites this paper
• HNSCC Biomarkers Derived from Key Processes of Cancerogenesis

  2016cites this paper
• Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2.

  2016cites this paper
• GPR171 expression enhances proliferation and metastasis of lung cancer cells

  2016cites this paper
• Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research

  2016cites this paper
• Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review

  2016cites this paper
• Dysregulation and detection methods of EGFR in oral cancer. A narrative review

  2016cites this paper
• Novel antitubulin agents uncover new players in microtubule regulation and cell division in cancer

  2016cites this paper
• Insights into bombesin receptors and ligands: Highlighting recent advances.

  2015cites this paper
• Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

  2015cites this paper
• Mechanisms of Invasion in Head and Neck Cancer.

  2015cites this paper
• The double trouble of metabolic diseases: the diabetes–cancer link

  2015cites this paper
• Monoclonal Antibodies for Cancer Immunotherapy

  2015cites this paper
• The endothelin axis in head and neck cancer: a promising therapeutic opportunity?

  2014cites this paper
• A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.

  2014cites this paper
• G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues.

  2014cites this paper
• Targeting the Sheddase Activity of ADAM17 by an Anti-ADAM17 Antibody D1(A12) Inhibits Head and Neck Squamous Cell Carcinoma Cell Proliferation and Motility via Blockage of Bradykinin Induced HERs Transactivation

  2014cites this paper
• RNA interference-mediated silencing of G protein-coupled receptor 137 inhibits human gastric cancer cell growth

  2014cites this paper
• The role of kinin receptors in cancer and therapeutic opportunities.

  2014cites this paper
• Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

  2014influential citation
• An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases.

  2013cites this paper
• Ripples in the pond--using a systems approach to decipher the cellular functions of membrane microdomains.

  2013cites this paper
• Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition

  2013cites this paper
• Epithelial wounds induce differential phosphorylation changes in response to purinergic and EGF receptor activation.

  2013cites this paper
• Role for membrane remodeling in cell death: implication for health and disease.

  2013cites this paper
• Nouveaux ligands du récepteur B₂ de la bradykinine : endocytose dirigée et catabolisme sélectif

  2013cites this paper
• Novel Combination Therapy: Monensin Potentiates Erlotinib-Induced Cytotoxicity.

  2013cites this paper
• Chemotherapy and molecularly targeted therapies for recurrent head and neck cancer

  2013cites this paper
• Integrated Cell-Based Platform to Study EGFR Activation and Transactivation

  2013cites this paper
• KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.

  2013cites this paper
• Personalized Management of Head & Neck Cancer

  2013cites this paper
• Antigen-specific immunotherapy in head and neck cancer

  2013cites this paper
• Signaling Pathways Coupled to Activation of the Kinin B1 Receptor

  2012cites this paper
• Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

  2012cites this paper
• Endothelin‐1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal–epithelial interactions

  2012cites this paper
• Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt.

  2012cites this paper
• The bradykinin B2 receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines

  2012cites this paper
• Kinin receptors as targets for cancer therapy

  2012cites this paper
• Hormonally active doses of isoflavone aglycones promote mammary and endometrial carcinogenesis and alter the molecular tumor environment in Donryu rats.

  2012cites this paper
• Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer

  2012influential citation
• The cytoplasmic rhodopsin-protein interface: potential for drug discovery.

  2012cites this paper
• Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.

  2012cites this paper
• Role Of Thromboxane Receptor-Alpha In Prostate Cancer Progression

  2012cites this paper
• The kallikrein-kinin-system in head and neck squamous cell carcinoma (HNSCC) and its role in tumour survival, invasion, migration and response to radiotherapy.

  2012cites this paper
• KISS1R Induces Human Mammary Epithelial Cell Invasiveness and Promotes Breast Cancer Cell Migration and Invasion via IQGAP1

  2012cites this paper
• Lipid rafts: signaling and sorting platforms of cells and their roles in cancer

  2011cites this paper
• EGF receptor activation by GPCRs: an universal pathway reveals different versions.

  2011cites this paper
• Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma

  2011cites this paper
• GIV/Girdin is a rheostat that fine-tunes growth factor signals during tumor progression

  2011cites this paper
• Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab

  2011influential citation
• HGF-independent Potentiation of EGFR Action by c-Met

  2011cites this paper
• Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells

  2011cites this paper
• Signaling pathways of ATP‐induced PGE2 release in spinal cord astrocytes are EGFR transactivation‐dependent

  2011influential citation
• The multiple roles of amphiregulin in human cancer.

  2011cites this paper
• Enforced Expression of miR-101 Inhibits Prostate Cancer Cell Growth by Modulating the COX-2 Pathway In Vivo

  2011cites this paper
• Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck.

  2011cites this paper
• Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the cyclooxygenase-2 pathway in vivo

  2011cites this paper
• Title Overexpression of GPR 39 contributes to malignant developmentof human esophageal squamous cell carcinoma

  2011cites this paper
• NF-κB addiction and its role in cancer: ‘one size does not fit all’

  2011cites this paper
• In vivo invasion of head and neck squamous cell carcinoma cells does not require macrophages.

  2011cites this paper
• Regulatory roles of calprotectin in head and neck squamous cell carcinogenesis.

  2011cites this paper
• Proliferative and survival pathways in oesophageal cancer

  2011cites this paper
• Analysis of the mammary gland specific effect of endothelin-1 in transgenic mice

  2011cites this paper
• Human b-defensin 3 promotes NF-kB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck

  2011cites this paper
• INFLAMMATORY MECHANISMS OF CHEMOKINE RECEPTOR 7 EXPRESSION IN METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)

  2011cites this paper
• 14 Kinins: kallikreins and kinins in cancer

  2011cites this paper
• Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer.

  2010cites this paper
• Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.

  2010cites this paper
• Role of epidermal growth factor inhibition in experimental pulmonary hypertension.

  2010cites this paper
• Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway

  2010cites this paper
• Progesterone is essential for maintenance of Tace/Adam17 mRNA expression, but not EGF-like factor, in cumulus cells, which enhances the EGF receptor signaling pathway during in vitro maturation of porcine COCs.

  2010cites this paper